Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

A key physiological feature of acute respiratory distress syndrome (ARDS) is inflammation. Toll-like receptor (TLR) signaling is required to combat the infection that underlies many ARDS cases but also contributes to pathological inflammation. Several TLR signaling pathway genes encoding positive effectors of inflammation also produce alternatively spliced mRNAs encoding negative regulators of inflammation. An imbalance between these isoforms could contribute to pathological inflammation and disease severity. To determine whether splicing in TLR pathways is altered in patients with ARDS, we monitored alternative splicing of MyD88 and IRAK1, two genes that function in multiple TLR pathways. The MyD88 and IRAK1 genes produce long proinflammatory mRNAs (MyD88L and IRAK1) and shorter anti-inflammatory mRNAs (MyD88S and IRAK1c). We quantified mRNA encoding inflammatory cytokines and MyD88 and IRAK1 isoforms in peripheral blood mononuclear cells (PBMCs) from 104 patients with ARDS and 30 healthy control subjects. We found that MyD88 pre-mRNA splicing is altered in patients with ARDS in a proinflammatory direction. We also observed altered MyD88 isoform levels in a second critically ill patient cohort, suggesting that these changes may not be unique to ARDS. Early in ARDS, PBMC IRAK1c levels were associated with patient survival. Despite the similarities in MyD88 and IRAK1 alternative splicing observed in previous in vitro studies, there were differences in how MyD88 and IRAK1 alternative splicing was altered in patients with ARDS. We conclude that pre-mRNA splicing of TLR signaling genes is altered in patients with ARDS, and further investigation of altered splicing may lead to novel prognostic and therapeutic approaches.

[1]  D. Macintire,et al.  Acute lung injury and acute respiratory distress syndrome , 2019, Analgesia, Anaesthesia and Pregnancy.

[2]  M. Strand,et al.  Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome , 2016, PloS one.

[3]  D. Chiumello,et al.  What's Next After ARDS: Long-Term Outcomes , 2016, Respiratory Care.

[4]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[5]  T. Rice,et al.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers , 2016, Intensive Care Medicine.

[6]  D. Hager.  Recent Advances in the Management of the Acute Respiratory Distress Syndrome. , 2015, Clinics in chest medicine.

[7]  B. O’Connor,et al.  Regulation of Toll-like Receptor Signaling by the SF3a mRNA Splicing Complex , 2015, PLoS genetics.

[8]  A. Peitzman,et al.  X Chromosome-Linked IRAK-1 Polymorphism Is a Strong Predictor of Multiple Organ Failure and Mortality Postinjury , 2014, Annals of surgery.

[9]  Annemieke Aartsma-Rus,et al.  Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases. , 2014, Experimental cell research.

[10]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[11]  T. Yokota,et al.  New developments in exon skipping and splice modulation therapies for neuromuscular diseases , 2014, Expert opinion on biological therapy.

[12]  S. Fujishima.  Pathophysiology and biomarkers of acute respiratory distress syndrome , 2014, Journal of Intensive Care.

[13]  G. Amerongen,et al.  Plasma Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis* , 2014, Critical care medicine.

[14]  G. Bernard,et al.  One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome , 2014, Intensive Care Medicine.

[15]  D. Schwartz,et al.  Comparative Genomics RNAi Screen Identifies Eftud2 as a Novel Regulator of Innate Immunity , 2013, Genetics.

[16]  S. Alper,et al.  Limiting of the Innate Immune Response by SF3A-Dependent Control of MyD88 Alternative mRNA Splicing , 2013, PLoS genetics.

[17]  Arthur S Slutsky,et al.  Acute respiratory distress syndrome: new definition, current and future therapeutic options. , 2013, Journal of thoracic disease.

[18]  G. van Ommen,et al.  Advances in therapeutic RNA-targeting. , 2013, New biotechnology.

[19]  G. van Ommen,et al.  Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP) , 2013, Molecular therapy. Nucleic acids.

[20]  T. Standiford,et al.  Danger‐associated molecular patterns (DAMPs) in acute lung injury , 2013, The Journal of pathology.

[21]  J. Andersson,et al.  Circulating Monocytes Are Not the Major Source of Plasma Cytokines in Patients With Sepsis , 2012, Shock.

[22]  C. Bai,et al.  Genetic variation in the TNF receptor-associated factor 6 gene is associated with susceptibility to sepsis-induced acute lung injury , 2012, Journal of Translational Medicine.

[23]  T. Cooper,et al.  Pre-mRNA splicing in disease and therapeutics. , 2012, Trends in molecular medicine.

[24]  D. Angus,et al.  The acute respiratory distress syndrome: what's in a name? , 2012, JAMA.

[25]  G. van Ommen,et al.  Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[26]  T. Rice,et al.  Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. , 2012, JAMA.

[27]  T. Rice,et al.  Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. , 2011, JAMA.

[28]  T. Standiford,et al.  Toll like receptors in diseases of the lung. , 2011, International immunopharmacology.

[29]  Lung,et al.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[30]  I. Douglas,et al.  Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome , 2011, PloS one.

[31]  N. Gay,et al.  What the Myddosome structure tells us about the initiation of innate immunity. , 2011, Trends in immunology.

[32]  V. Viallon,et al.  IRAK1 functional genetic variant affects severity of septic shock* , 2010, Critical care medicine.

[33]  R. Glenny,et al.  Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study , 2010, BMC pulmonary medicine.

[34]  M. Matthay,et al.  Acute lung injury: epidemiology, pathogenesis, and treatment. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[35]  K. Brown,et al.  A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: Aetiology and outcomes , 2010, Respirology.

[36]  F. Granucci,et al.  Deciphering the complexity of Toll-like receptor signaling , 2010, Cellular and Molecular Life Sciences.

[37]  D. Underhill,et al.  Identification of a Novel Human MD-2 Splice Variant That Negatively Regulates Lipopolysaccharide-Induced TLR4 Signaling , 2010, The Journal of Immunology.

[38]  Y. Lo,et al.  Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.

[39]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[40]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[41]  Jie Fan,et al.  Pattern Recognition Receptor–Dependent Mechanisms of Acute Lung Injury , 2009, Molecular medicine.

[42]  C. Robinson,et al.  An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4* , 2009, The Journal of Biological Chemistry.

[43]  K. Barnes,et al.  Recent advances in genetic predisposition to clinical acute lung injury. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[44]  E. López-Collazo,et al.  Contribution of globular death domains and unstructured linkers to MyD88.IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s. , 2009, Biochemical and biophysical research communications.

[45]  T. Gilmore,et al.  Alternative splicing in the NF-kappaB signaling pathway. , 2008, Gene.

[46]  R. Salomão,et al.  TLR signaling pathway in patients with sepsis. , 2008, Shock.

[47]  R. Kole,et al.  An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  E. Abraham,et al.  Variant IL-1 Receptor-Associated Kinase-1 Mediates Increased NF-κB Activity1 , 2007, The Journal of Immunology.

[49]  A. Šedivá,et al.  Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. , 2007, Microbes and infection.

[50]  G. Bernard,et al.  Acute lung injury and the acute respiratory distress syndrome: a clinical review , 2007, The Lancet.

[51]  Q. Gu,et al.  Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants. , 2007, Molecular immunology.

[52]  Rudi Beyaert,et al.  Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients* , 2006, Critical care medicine.

[53]  L. Ware.  Pathophysiology of acute lung injury and the acute respiratory distress syndrome. , 2006, Seminars in respiratory and critical care medicine.

[54]  E. Abraham,et al.  Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. , 2006, American journal of respiratory and critical care medicine.

[55]  N. Dean,et al.  Modification of MyD88 mRNA Splicing and Inhibition of IL-1β Signaling in Cell Culture and in Mice with a 2′-O-Methoxyethyl-Modified Oligonucleotide , 2006, The Journal of Immunology.

[56]  Jun Kawai,et al.  Alternate transcription of the Toll-like receptor signaling cascade , 2006, Genome Biology.

[57]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[58]  W. Fung-Leung,et al.  A Novel Splice Variant of Interleukin-1 Receptor (IL-1R)-Associated Kinase 1 Plays a Negative Regulatory Role in Toll/IL-1R-Induced Inflammatory Signaling , 2005, Molecular and Cellular Biology.

[59]  G. Bernard,et al.  Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.

[60]  Kristen W. Lynch,et al.  Consequences of regulated pre-mRNA splicing in the immune system , 2004, Nature Reviews Immunology.

[61]  S. Ohta,et al.  Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling. , 2004, Biochemical and biophysical research communications.

[62]  Demosthenes Bouros,et al.  The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome , 2004, BMC pulmonary medicine.

[63]  M. Hardy,et al.  The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.

[64]  S. Moochhala,et al.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome , 2004, The Journal of pathology.

[65]  J. Tschopp,et al.  MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.

[66]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[67]  J. Tschopp,et al.  Regulation of Interleukin-1- and Lipopolysaccharide-Induced NF-κB Activation by Alternative Splicing of MyD88 , 2002, Current Biology.

[68]  S. Humphries,et al.  Genetic polymorphisms associated with susceptibility and outcome in ARDS. , 2002, Chest.

[69]  A. Masuda,et al.  Cutting Edge: Naturally Occurring Soluble Form of Mouse Toll-Like Receptor 4 Inhibits Lipopolysaccharide Signaling1 , 2000, The Journal of Immunology.

[70]  J. Nicolás,et al.  Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls , 2000, Thorax.

[71]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[72]  W. Seeger,et al.  Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. , 1996, The European respiratory journal.

[73]  F. Stentz,et al.  Clinical Investigations in Critical CareInflammatory Cytokines in the BAL of Patients With ARDS: Persistent Elevation Over Time Predicts Poor Outcome , 1995 .

[74]  F. Stentz,et al.  Clinical Investigations in Critical CarePersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS: Plasma IL-1β and IL-6 Levels Are Consistent and Efficient Predictors of Outcome Over Time , 1995 .

[75]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[76]  J. Cavaillon,et al.  Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.

[77]  J. Cavaillon,et al.  Dissociation between plasma and monocyte‐associated cytokines during sepsis , 1991, European journal of immunology.

[78]  C. Haslett,et al.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.

[79]  Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial , 2012 .

[80]  K. Zacharowski,et al.  Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. , 2009, Critical care medicine.

[81]  E. Abraham,et al.  Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. , 2007, Journal of immunology.

[82]  B. Sullenger,et al.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing , 2003 .